WASHINGTON (February 4, 2025) — The Association for Accessible Medicines today published their 2025 advocacy priorities and regulatory and legislative reform recommendations: Protect and Defend
WASHINGTON (February 2, 2025) — The Association for Accessible Medicines today commented on the announcement that a 25% tariff will be imposed on Canada and
WASHINGTON (January 22, 2025) — The Board of Directors of the Association for Accessible Medicines has reelected as Chair for a second one-year term, Keren
WASHINGTON (January 17, 2025) — The Association for Accessible Medicines, the trade association for generic and biosimilar manufacturers, today commented on the release of fifteen
Skinny labels allow quicker market entry of generic and biosimilar competition, reducing prices across the healthcare landscape WASHINGTON (December 19, 2024) — Since the passage
Encourages Congress to pass critically important healthcare provisions WASHINGTON, DC (December 18, 2024) – The Association for Accessible Medicines, the trade association for generic and
Avalere analysis finds 57% of covered generic drugs not on Part D generic tiers in 2025 WASHINGTON, DC (December 10, 2024) – The Association for
WASHINGTON, DC (November 7, 2024) — The Association for Accessible Medicines and the Biosimilars Council today released the following statement from President and CEO John
Does not address PBM abuses or ensure generic sustainability WASHINGTON, DC (October 16, 2024) – The Association for Accessible Medicines today commented on the Centers
Congress encouraged to stop patent abuses and eliminate biosimilar misinformation WASHINGTON (September 24, 2024) — On the anniversary of the enactment of the Hatch-Waxman Act
Brings years of industry, policy, and association leadership experience WASHINGTON, DC (September 25, 2024) – The Association for Accessible Medicines Board of Directors today announced
Future patient access and savings at risk without action WASHINGTON (September 24, 2024) — Today marks the 40th Anniversary of the enactment of Hatch-Waxman, the
